Women are Not at Higher Risk for Reintervention or Major Amputation after Lower Extremity Atherectomy for Peripheral Artery Disease

医学 动脉切除术 截肢 外科 血管成形术 气球 跛行 动脉疾病 严重肢体缺血 血管疾病 内科学 心脏病学 再狭窄 支架
作者
Nikita Israni,Jonathan Lee,Halbert Bai,Jason B. Storch,Jenny Chen,Peter V. Cooke,Olivia Blanchard,Sung Yup Kim,Rami O. Tadros,R. Lookstein,Peter L. Faries,Ageliki G. Vouyouka
出处
期刊:Annals of Vascular Surgery [Elsevier BV]
卷期号:95: 95-107 被引量:3
标识
DOI:10.1016/j.avsg.2023.04.001
摘要

Background Our objective was to compare short-term and long-term differences in reintervention-free and major amputation-free survival between female and male patients undergoing lower extremity atherectomy for peripheral artery disease. Methods We analyzed lower extremity atherectomy procedures performed on 294 patients between January 2014 and September 2019. Reintervention was defined as either open bypass or endovascular procedure to the same region following the index operation. Kaplan-Meier (KM) survival analysis was performed to compare reintervention-free and major amputation-free survival between sexes. Multivariate logistic regression analyses were performed to determine the adjusted odds of reintervention and major amputation based on sex. We conducted subgroup analyses by anatomic region (femoropopliteal vs. tibial), indication (claudication vs. chronic limb-threatening ischemia (CLTI)), and balloon type (drug-coated balloon (DCB) versus plain balloon angioplasty (POBA)) across sexes. Results Of the 294 patients, 125 (42.5%) were female. Compared to men, women receiving atherectomy were more likely to be Black (28.0% vs. 16.6%; P = 0.018), a nonsmoker (44.8% vs. 21.3%; P < 0.001), and present with CLTI (55.2% vs. 43.2%; P = 0.042). There were no differences in atherectomy region, lesion type, or balloon type between sexes. KM analysis showed similar 4-year reintervention-free survival (68.8% vs. 75.1%; P = 0.88) and major amputation-free survival (97.6% vs. 97.6%; P = 0.41) between sexes. Women and men had similar reintervention-free survival when grouped by femoropopliteal (67.9% vs. 70.8%; P = 0.69) or tibial (76.2% vs. 83.9%; P = 0.68) atherectomy region. Indication (claudication versus CLTI) did not affect reintervention-free survival in either women (64.5% vs. 69.6%; P = 0.28) or men (68.5% vs. 76.7%; P = 0.84). KM curves for DCB versus POBA were also similar between sexes and showed an early benefit in reintervention rate favoring DCB, which dissipated in both women (65.4% vs. 72.7%; P = 0.61) and men (75.5% vs. 78.4%; P = 0.18) by 3 years. Conclusions Compared to men, women demonstrate commensurate benefit from atherectomy for lower extremity revascularization. There were no differences seen in long-term reintervention or major amputation between sexes. Our objective was to compare short-term and long-term differences in reintervention-free and major amputation-free survival between female and male patients undergoing lower extremity atherectomy for peripheral artery disease. We analyzed lower extremity atherectomy procedures performed on 294 patients between January 2014 and September 2019. Reintervention was defined as either open bypass or endovascular procedure to the same region following the index operation. Kaplan-Meier (KM) survival analysis was performed to compare reintervention-free and major amputation-free survival between sexes. Multivariate logistic regression analyses were performed to determine the adjusted odds of reintervention and major amputation based on sex. We conducted subgroup analyses by anatomic region (femoropopliteal vs. tibial), indication (claudication vs. chronic limb-threatening ischemia (CLTI)), and balloon type (drug-coated balloon (DCB) versus plain balloon angioplasty (POBA)) across sexes. Of the 294 patients, 125 (42.5%) were female. Compared to men, women receiving atherectomy were more likely to be Black (28.0% vs. 16.6%; P = 0.018), a nonsmoker (44.8% vs. 21.3%; P < 0.001), and present with CLTI (55.2% vs. 43.2%; P = 0.042). There were no differences in atherectomy region, lesion type, or balloon type between sexes. KM analysis showed similar 4-year reintervention-free survival (68.8% vs. 75.1%; P = 0.88) and major amputation-free survival (97.6% vs. 97.6%; P = 0.41) between sexes. Women and men had similar reintervention-free survival when grouped by femoropopliteal (67.9% vs. 70.8%; P = 0.69) or tibial (76.2% vs. 83.9%; P = 0.68) atherectomy region. Indication (claudication versus CLTI) did not affect reintervention-free survival in either women (64.5% vs. 69.6%; P = 0.28) or men (68.5% vs. 76.7%; P = 0.84). KM curves for DCB versus POBA were also similar between sexes and showed an early benefit in reintervention rate favoring DCB, which dissipated in both women (65.4% vs. 72.7%; P = 0.61) and men (75.5% vs. 78.4%; P = 0.18) by 3 years. Compared to men, women demonstrate commensurate benefit from atherectomy for lower extremity revascularization. There were no differences seen in long-term reintervention or major amputation between sexes.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
按时毕业吧少年完成签到,获得积分10
刚刚
回去完成签到,获得积分10
1秒前
1秒前
1秒前
1秒前
上官若男的应助被暮雪采纳,获得30
2秒前
无花果的应助被苗条梨愁采纳,获得10
2秒前
2026221709发布了新的文献求助10
2秒前
bitter完成签到 ,获得积分10
2秒前
4秒前
田様的应助被ArArAr采纳,获得10
5秒前
6秒前
Lucas的应助被天空采纳,获得10
6秒前
6秒前
王某某发布了新的文献求助10
7秒前
7秒前
按时间好家伙完成签到,获得积分10
8秒前
NexusExplorer的应助被和谐的寒风采纳,获得10
9秒前
EstAffectus发布了新的文献求助10
9秒前
10秒前
bichumao完成签到,获得积分10
11秒前
qian发布了新的文献求助10
12秒前
13秒前
14秒前
15秒前
why完成签到,获得积分10
15秒前
GG完成签到,获得积分20
16秒前
16秒前
今后的应助被坚定的采波采纳,获得10
16秒前
orixero的应助被369ninja采纳,获得10
17秒前
科目三的应助被AthurMarcus采纳,获得30
17秒前
秋风的应助被AthurMarcus采纳,获得10
17秒前
17秒前
小蘑菇的应助被AthurMarcus采纳,获得30
17秒前
情怀的应助被AthurMarcus采纳,获得10
18秒前
秋风的应助被AthurMarcus采纳,获得10
18秒前
英俊的铭的应助被AthurMarcus采纳,获得10
18秒前
科目三的应助被吃猫的锦鲤采纳,获得10
18秒前
19秒前
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184462
求助须知:如何正确求助?哪些是违规求助? 9573447
关于积分的说明 21831674
捐赠科研通 7781651
什么是DOI,文献DOI怎么找? 3434363
关于科研通互助平台的介绍 2558468
邀请新用户注册赠送积分活动 2480923